1. Blame the bonds: The normally boring bond market is causing serious drama on Wall Street.
An avalanche of selling sent the Dow and S&P 500 careening 5% lower last week, one of the stock market’s worst weeks since the 2008 financial crisis.
The culprit: Rapidly rising bond yields are alarming investors who got hooked on a decade of low interest rates.
So what’s going on here? And why the focus on the bond market?
Modern financial markets function on the belief that U.S. government debt is the safest investment on the planet.
Knowing how much they can earn from “risk-free” Treasury bonds allows investors to determine the cost of stocks and other riskier assets. Treasuries serve as the benchmark for all other forms of credit, from junk bonds to mortgages.
“The 10-year Treasury sets the price for every asset in the world,” said Brent Schutte, chief investment strategist at Northwestern Mutual.
That means the surge in the 10-year yield from 2.4% earlier this year to about 2.8% now — has increased the cost of money generally.
Top 5 Safest Stocks To Invest In 2018: Trevena, Inc.(TRVN)
- [By Chris Lange]
Trevena Inc. (NASDAQ: TRVN) reported positive results from two late-stage clinical trials that work to treat post-surgical pain. The company intends to submit these results to the FDA for a marketing approval agreement in the fourth quarter. Previously, oliceridine was approved for a breakthrough designation by the agency.
- [By Paul Ausick]
Trevena Inc. (NASDAQ: TRVN) dropped about 6.3% Thursday, to post a new 52-week low of $3.70 after closing at $3.95 on Wednesday. The stock’s 52-week high is $9.73. Volume was nearly 5 times the daily average of around 700,000 shares. The company’s pain-killing drug got mixed results in a trial result reported Tuesday.
- [By Lisa Levin]
Trevena Inc (NASDAQ: TRVN) shares dropped 36 percent to $4.55 despite a positive development in Phase 3 trials. Trevena announced positive top-line results from ongoing Phase 3 trials called "APOLLO-1" and "APOLLO-2." The studies evaluated the safety of Trevena's oliceridine therapy in patients for 48 hours following bunionectomy and 24 hours following abdominoplasty.
- [By Lisa Levin] Gainers
Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
- [By Maxx Chatsko]
Shares of clinical-stage biopharma Trevena (NASDAQ:TRVN) fell nearly 12% today after it reported full-year 2016 earnings. The pre-revenue company didn’t announce any surprises one way or the other. However, investors appear to be considering the near-term consequences of swelling expenses that won’t be offset by product sales anytime soon.
Top 5 Safest Stocks To Invest In 2018: Oxford Industries Inc.(OXM)
- [By Ben Levisohn]
Looking at recent historical deals, we arrive at a $18-$23 potential deal range. We analyzed transactions that have been announced over the past four years and involved companies catering to a higher income customer. These deals include Southern Tide (acquired by Oxford Industries (OXM)), Joe’s Jeans (acquired by Sequential Brands Group (SQBG)), prAna (acquired by Columbia Sportswear (COLM)), The Jones Group (acquired by Sycamore Partners [private] and Juicy Couture (acquired by Authentic Brands Group [private]). The average EV/EBITDA multiple of these transactions are 12.9x (in line with KATE’s 5-year historical average of 12.1x) and implies a potential deal range of $22-$23. When taking the average of recent (F13-16) deals implies an ~10.5x EV/EBITDA multiple. When applying the ~10.5x multiples to KATE’s trailing EBITDA, we arrive at an $18- $19 potential share price.
- [By Lisa Levin]
Oxford Industries Inc (NYSE: OXM) was down, falling around 11 percent to $64.05. Oxford Industries reported a narrower-than-expected loss for its third quarter. The company projects full-year earnings of $3.50 to $3.65 per share, and revenue of $1.02 billion to $1.03 billion.
Top 5 Safest Stocks To Invest In 2018: Cognizant Technology Solutions Corporation(CTSH)
- [By Monica Gerson]
Cognizant Technology Solutions Corp (NASDAQ: CTSH) is estimated to report its quarterly earnings at $0.79 per share on revenue of $3.23 billion.
CIGNA Corporation (NYSE: CI) is projected to report its quarterly earnings at $2.15 per share on revenue of $10.00 billion.
- [By Shanthi Rexaline]
The industry — valued at over $150 billion and comprising companies such as Wipro Limited (ADR) (NYSE: WIT), Cognizant Technology Solutions Corp (NASDAQ: CTSH), Infosys Ltd ADR (NYSE: INFY) and Tata Consultancy Services — has thus far been competing effectively on certain unique selling propositions such as low-cost technology skills and high quality manpower.
- [By Monica Gerson]
Analysts expect Cognizant Technology Solutions Corp (NASDAQ: CTSH) to report its quarterly earnings at $0.79 per share on revenue of $3.23 billion. Cognizant Technology shares gained 1.75 percent to $58.60 in after-hours trading.
- [By WWW.THESTREET.COM]
And Elliott could be pressuring two public companies to combine. One company that analysts contend could be interested in buying Advisory Board’s healthcare business, which represents about 80% of the company, is Cognizant Technology Solutions (CTSH) . The Teaneck, N.J.-based business has been under pressure in recent months by Elliott Management to take on more leverage to help fund research and M&A.
Top 5 Safest Stocks To Invest In 2018: Apricus Biosciences, Inc(APRI)
- [By William Romov]
California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).
- [By Chris Lange]
Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDAs review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.
- [By Jon C. Ogg]
The biotechs and emerging pharma havebeen under pressure from politicians attacking drug prices. That doesn’t mean that there are not some big winners out there. Sometimes the biggest winners are companies most investors have never heard of. Even if you have been a biotech and emerging pharma investor for years, chances are high that you would have never heard of a small outfit called Apricus Biosciences Inc. (NASDAQ: APRI).
Top 5 Safest Stocks To Invest In 2018: PetroChina Company Limited(PTR)
- [By Money Morning News Team]
PetroChina Co. Ltd. (NYSE ADR: PTR) is China’s largest oil company with a market cap of $216.52 billion. PTR is partially owned by the Chinese government.